Example: Heart Attack

Clinical Trials on Malignant Mixed Mullerian Tumor

Total 94 results

NCT00502203

Completed

Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

Conditions: Mixed Tumor, Mullerian
NCT03651206

Recruiting

Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib

Conditions: Ovarian Carcinosarcoma; Endometrial Carcinosarcoma
NCT02993705

Active, not recruiting

Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)

Conditions: Carcinosarcoma, Ovarian; Carcinosarcomas Uterine
NCT03206177

Recruiting

Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary

Conditions: Carcinosarcoma, Ovarian
NCT00687687

Completed

Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma

Conditions: Uterine Carcinosarcoma
NCT04149275

Withdrawn

Cabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma

Conditions: Carcinosarcoma of Ovary; Carcinosarcoma of Uterus; Carcinosarcoma of Vagina
NCT00476086

Completed

Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus

Conditions: Mixed Mullerian Tumors of the Uterus
NCT04106414

Recruiting

Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment

Conditions: Endometrial Adenocarcinoma; Endometrial Carcinosarcoma
NCT00025506

Completed

Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus

Conditions: Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
NCT03933761

Recruiting

Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy

Conditions: Ovarian Cancer; Carcinosarcoma
NCT02203760

Recruiting

Pazopanib vs. Pazopanib Plus Gemcitabine

Conditions: Leiomyosarcoma or Carcinosarcoma
NCT04513665

Recruiting

ZW25 in Women With Endometrial Cancers

Conditions: Endometrial Cancer; Carcinosarcoma
NCT01247571

Completed

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

Conditions: Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
NCT01168232

Completed

Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

Conditions: Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
NCT01061606

Terminated

Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Conditions: Recurrent Uterine Sarcoma; Uterine Carcinosarcoma
NCT00114218

Completed

Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer

Conditions: Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
NCT00075400

Completed

Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer

Conditions: Recurrent Uterine Sarcoma; Uterine Carcinosarcoma
NCT02964351

Unknown status

microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer

Conditions: Prostate Carcinosarcoma
NCT03395080

Active, not recruiting

A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma

Conditions: Endometrial Cancer; Uterine Cancer; Ovarian Cancer; Carcinosarcoma
NCT02090127

No longer available

Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient

Conditions: Mullerian Mixed Tumor of Ovary
NCT00505492

Terminated

Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy

Conditions: Uterine Neoplasms
NCT00520013

Completed

Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors

Conditions: Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer; Papillary Serous Mullerian Tumor; Clear Cell Mullerian Tumor
NCT01991808

Completed

Suitability of DCE-MRI for Detection of Vascular Changes After VBT

Conditions: Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus
NCT03668340

Recruiting

AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma

Conditions: Uterine Cancer
NCT03570437

Recruiting

Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?

Conditions: Carcinosarcoma; Endometrial Neoplasms